CYCCP
Price
$4.28
Change
+$0.22 (+5.42%)
Updated
Aug 7 closing price
Capitalization
N/A
TECH
Price
$50.42
Change
+$0.27 (+0.54%)
Updated
Aug 8, 04:47 PM (EDT)
Capitalization
7.86B
88 days until earnings call
Interact to see
Advertisement

CYCCP vs TECH

Header iconCYCCP vs TECH Comparison
Open Charts CYCCP vs TECHBanner chart's image
Cyclacel Pharmaceuticals
Price$4.28
Change+$0.22 (+5.42%)
Volume$505
CapitalizationN/A
Bio-Techne
Price$50.42
Change+$0.27 (+0.54%)
Volume$6.87K
Capitalization7.86B
CYCCP vs TECH Comparison Chart in %
Loading...
CYCCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCCP vs. TECH commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCCP is a Hold and TECH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (CYCCP: $4.28 vs. TECH: $50.15)
Brand notoriety: CYCCP and TECH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCCP: 9% vs. TECH: 140%
Market capitalization -- CYCCP: $0 vs. TECH: $7.86B
CYCCP [@Biotechnology] is valued at $0. TECH’s [@Biotechnology] market capitalization is $7.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCCP’s FA Score shows that 1 FA rating(s) are green whileTECH’s FA Score has 2 green FA rating(s).

  • CYCCP’s FA Score: 1 green, 4 red.
  • TECH’s FA Score: 2 green, 3 red.
According to our system of comparison, TECH is a better buy in the long-term than CYCCP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCCP’s TA Score shows that 5 TA indicator(s) are bullish while TECH’s TA Score has 3 bullish TA indicator(s).

  • CYCCP’s TA Score: 5 bullish, 4 bearish.
  • TECH’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CYCCP is a better buy in the short-term than TECH.

Price Growth

CYCCP (@Biotechnology) experienced а +5.42% price change this week, while TECH (@Biotechnology) price change was -8.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.21%. For the same industry, the average monthly price growth was +6.59%, and the average quarterly price growth was +12.79%.

Reported Earning Dates

TECH is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+0.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH YTD gains are higher at: -30.179 vs. CYCCP (-37.551). TECH has higher annual earnings (EBITDA): 283M vs. CYCCP (-12.68M). TECH has more cash in the bank: 141M vs. CYCCP (93K). CYCCP has less debt than TECH: CYCCP (9K) vs TECH (423M). TECH has higher revenues than CYCCP: TECH (1.21B) vs CYCCP (14K).
CYCCPTECHCYCCP / TECH
CapitalizationN/A7.86B-
EBITDA-12.68M283M-4%
Gain YTD-37.551-30.179124%
P/E RatioN/A109.02-
Revenue14K1.21B0%
Total Cash93K141M0%
Total Debt9K423M0%
FUNDAMENTALS RATINGS
CYCCP vs TECH: Fundamental Ratings
CYCCP
TECH
OUTLOOK RATING
1..100
8156
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10080
PRICE GROWTH RATING
1..100
6564
P/E GROWTH RATING
1..100
10014
SEASONALITY SCORE
1..100
4575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYCCP's Valuation (1) in the Biotechnology industry is in the same range as TECH (4). This means that CYCCP’s stock grew similarly to TECH’s over the last 12 months.

CYCCP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as TECH (100). This means that CYCCP’s stock grew similarly to TECH’s over the last 12 months.

TECH's SMR Rating (80) in the Biotechnology industry is in the same range as CYCCP (100). This means that TECH’s stock grew similarly to CYCCP’s over the last 12 months.

TECH's Price Growth Rating (64) in the Biotechnology industry is in the same range as CYCCP (65). This means that TECH’s stock grew similarly to CYCCP’s over the last 12 months.

TECH's P/E Growth Rating (14) in the Biotechnology industry is significantly better than the same rating for CYCCP (100). This means that TECH’s stock grew significantly faster than CYCCP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYCCPTECH
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
66%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 15 days ago
71%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 3 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
CYCCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFNEX88.760.03
+0.03%
American Funds Fundamental Invs 529E
BGEIX20.32N/A
N/A
American Century Global Gold Inv
AFEIX55.37N/A
N/A
American Century Large Cap Equity I
HULEX34.21N/A
N/A
Huber Select Large Cap Value Instl
MLORX8.80-0.05
-0.56%
Cohen & Steers Future of Energy R

CYCCP and

Correlation & Price change

A.I.dvisor tells us that CYCCP and VALN have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCCP and VALN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCCP
1D Price
Change %
CYCCP100%
+5.42%
VALN - CYCCP
24%
Poorly correlated
+4.19%
SRPT - CYCCP
23%
Poorly correlated
+10.46%
AURA - CYCCP
21%
Poorly correlated
-1.21%
KZIA - CYCCP
21%
Poorly correlated
-4.96%
TECH - CYCCP
21%
Poorly correlated
+0.56%
More